Febbo Phillip G. (CIK 1649245) reported 16 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-10). Recent activity: Buy VCYT (29,603 shares), Buy VCYT (6,578 shares), Sell VCYT (6,035 shares), Sell VCYT (13,425 shares), Buy VCYT (71,806 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-10 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Buy | 29,603 | $0 |
| 2026-03-10 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Buy | 6,578 | $0 |
| 2026-03-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 6,035 | $217,320 |
| 2026-03-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 13,425 | $485,448 |
| 2026-03-02 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Buy | 71,806 | $0 |
| 2026-03-02 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 24,486 | $948,832 |
| 2025-12-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 2,955 | $136,403 |
| 2025-10-07 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 8,349 | $300,731 |
| 2025-09-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 2,955 | $88,975 |
| 2025-06-04 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 2,955 | $79,017 |
| 2025-03-10 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Buy | 24,160 | $0 |
| 2025-03-06 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 4,467 | $146,786 |
| 2025-03-06 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 3,570 | $121,202 |
| 2025-03-03 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Buy | 30,589 | $0 |
| 2025-03-03 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 15,672 | $530,340 |
| 2025-03-03 | VERACYTE, INC. (VCYT) | Chief Scientific & Med Officer | Sell | 6,754 | $234,769 |
Source: SEC Form 4 filings · as of 2026-03-10